Trends in Pharmacological Sciences
ViewpointLipocortin-1: cellular mechanisms and clinical relevance
References (35)
- et al.
J. Biol. Chem.
(1991) - et al.
Biochem. Biophys. Res. Commun.
(1993) - et al.
J. Biol. Chem.
(1989) - et al.
FEBS Lett.
(1991) Lancet
(1990)- et al.
Brain Res.
(1991) - et al.
Neurosci. Biobehav. Rev.
(1993) Br. J. Pharmacol.
(1988)Nature
(1986)- et al.
J. Cell. Physiol.
(1989)
Biochem. Soc. Trans.
Br. J. Pharmacol.
Endocrinology
J. Appl. Physiol.
Cited by (336)
Glucocorticoids and COVID-19
2022, Pharmacological ResearchCitation Excerpt :The majority of mechanisms involved in the anti-inflammatory activity of GCs are attributed to the direct modulation of gene transcription, including regulation of genes that control cell activation and production of mediators of inflammation [18]. As an example, GCs influence prostaglandin (PG) synthesis, by interaction with GRs, that are transcription factors, and by transcriptional up-regulation of the glucocorticoid-induced leucine zipper (GILZ), and consequently of Annexin-1, which then counters phospholipase A2 (PLA2) activity and arachidonic acid (a precursor in the synthesis of prostanoids) release, a mechanism also involved in GC-regulated apoptosis [31,32]. Moreover, GCs inhibit the cyclooxygenases (COXs) and consequently the metabolism of arachidonic acid [17,33,34].
Annexin A protein family in atherosclerosis
2022, Clinica Chimica ActaRoles of Annexin A protein family in autophagy regulation and therapy
2020, Biomedicine and PharmacotherapyNew markers in ulcerative colitis
2019, Clinica Chimica ActaMast cell heterogeneity and anti-inflammatory annexin A1 expression in leprosy skin lesions
2018, Microbial PathogenesisInfectious pancreatic necrosis virus infection of fish cell lines: Preliminary analysis of gene expressions related to extracellular matrix remodeling and immunity
2017, Veterinary Immunology and Immunopathology